All News

Johnson & Johnson announced it will reduce its workforce and restructure.

Embrace transitions.

The federal government has charged Mylan Laboratories with attempting to create a monopoly within the pharmaceutical industry.

One of the hardest silos to break down in any cross-functional sales effort is the pernicious and often impenetrable wall that has grown up between the sales and marketing functions.

Where and how a compensation plan can make an impact.

E. Fougera & Co. will celebrate its sesquicentennial this year, the Long Island, NY-based generic pharmaceuticals company announced.

Along with self-discipline, David Kazan Jr. attributes 20 successful years in pharmaceutical sales to a lasting commitment to his customers.

Record spending in research and development by pharmaceutical companies contributed to the FDA approval of 30 new drugs and nine new biologics in 1998, according to a report from Washington-based Pharmaceutical Research and Manufacturers of America.

Warner-Lambert Co. will buy Agouron Pharmaceuticals, La Jolla, CA, the Morris Plains, NJ-based company announced.

Carve-ins, hybrid models for disease management, are evolving out of integrated delivery systems and carve-out companies, according to a new report from Decision Resources.

Make home base a pleasant place.

Are FDA and DEA officials watching you?

Making a good impression with the boss.

Novartis released its 1998 Pharmacy Benefit Report, a compilation of 1997 pharmacy benefit facts and figures gathered by independent researchers and analysts.

Befriend the person who controls office access.

Zeneca Group and Astra AB announced that they plan to merge.

Define your success.

Medicine's latest subspecialty offers opportunities to control costs.

Does the United States need an independent drug safety board to investigate FDA-approved medicines?

Follow the examples of those who see the lighter side of life.

Hoechst Marion Roussel and Rhône-Poulenc Rorer announced they plan to boost their combined sales force to 4,000 reps.

The American Medical Womens' Association met to discuss current and emerging issues that affect women physicians and issues in women's health.

The AMA examined the pharmaceutical industry's use of confidential patient prescribing data during its annual meeting.

The pharmaceutical industry sharply criticized new legislation that proposes offering Medicare beneficiaries deep pricing discounts on prescription medicines.

Hospital-based registered nurses report that fewer patients are being harmed by medical errors than was the case 10 years ago.

Understand three key issues.

The annual rate of change for prescription pharmaceutical prices in the United States held at 3.4% in the third quarter of 1998, compared to the third quarter of 1997.

Direct-to-consumer advertising appears to be having its desired effect.

Jill Shoffner-Brown loves satisfying the customer and hearing success stories about her products.

Hiring good professionals will make life easier and keep you on the law's good side.